ARCHIVES

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

Brain tumor foundations form collaboration.

July 15, 2005

In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy

April 28, 1995

FDA Approves HPV Test

April 25, 2003

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014